BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16247272)

  • 21. [Prognosis of hepatocellular carcinoma according to new staging classifications].
    Caselitz M; Masche N; Flemming P; Stern C; Manns MP; Wagner S; Kubicka S
    Dtsch Med Wochenschr; 2004 Aug; 129(33):1725-30. PubMed ID: 15295682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognosis and survival analysis according to seven staging systems of hepatocellular carcinoma following curative resection.
    Choi SB; Lee JG; Kim KS; Yoon DS; Choi JS; Lee WJ; Kim BR
    Hepatogastroenterology; 2008; 55(88):2140-5. PubMed ID: 19260493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective comparison with previously known prognostic models.
    Baek KK; Kim JH; Uhm JE; Park SH; Lee J; Park JO; Park YS; Kang WK; Lim HY
    Oncology; 2011; 80(3-4):167-74. PubMed ID: 21701230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Survival and prognostic analysis of radiofrequency ablation of hepatocellular carcinoma].
    Yang W; Chen MH; Gao W; Wu W; Huo L; Dai WD; Liu WY; Yan K
    Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):169-73. PubMed ID: 16635345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.
    Li X; Dong M; Lin Q; Chen ZH; Ma XK; Xing YF; Wan XB; Wen JY; Wei L; Chen J; Wu XY
    Asia Pac J Clin Oncol; 2013 Mar; 9(1):86-92. PubMed ID: 23279888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators.
    Hepatology; 1998 Sep; 28(3):751-5. PubMed ID: 9731568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proposal of the performance status combined Japan Integrated Staging system in hepatocellular carcinoma complicated with cirrhosis.
    Nishikawa H; Kita R; Kimura T; Endo M; Ohara Y; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Osaki Y
    Int J Oncol; 2015; 46(6):2371-9. PubMed ID: 25891119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort.
    op den Winkel M; Nagel D; Sappl J; op den Winkel P; Lamerz R; Zech CJ; Straub G; Nickel T; Rentsch M; Stieber P; Göke B; Kolligs FT
    PLoS One; 2012; 7(10):e45066. PubMed ID: 23071507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival improvement in Child-Pugh C cirrhotic patients with hepatocellular carcinoma diagnosed during 1990-2002.
    Ollivier I; Dauvois B; Guittet L; Boutreux S; Dupont B; Launoy G; Dao T
    Gastroenterol Clin Biol; 2010; 34(4-5):288-96. PubMed ID: 20189339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
    Hiraoka A; Kumada T; Michitaka K; Toyoda H; Tada T; Ueki H; Kaneto M; Aibiki T; Okudaira T; Kawakami T; Kawamura T; Yamago H; Suga Y; Miyamoto Y; Tomida H; Azemoto N; Mori K; Miyata H; Ninomiya T; Kawasaki H
    J Gastroenterol Hepatol; 2016 May; 31(5):1031-6. PubMed ID: 26647219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new staging system is more discriminant than conventional staging systems for unresectable hepatocellular carcinoma.
    Zhang BH; Wang XH; Yue HY; Ling CQ
    J Cancer Res Clin Oncol; 2010 Jun; 136(6):821-7. PubMed ID: 19916022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
    Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
    Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
    Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma.
    Omagari K; Honda S; Kadokawa Y; Isomoto H; Takeshima F; Hayashida K; Mizuta Y; Murata I; Kohno S
    J Gastroenterol Hepatol; 2004 Jul; 19(7):805-11. PubMed ID: 15209629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of prognostic factors after curative resection for combined hepatocellular and cholangiocarcinoma].
    Kim W; Lee JH; Kim YJ; Yoon JH; Suh KS; Lee KU; Jang JJ; Lee HS
    Korean J Gastroenterol; 2007 Mar; 49(3):158-65. PubMed ID: 18172344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis predictability of hepatocellular carcinoma according to staging systems in hepatitis B virus-endemic area.
    Kang HY; Shin HD; Kim SB; Song IH
    Clin Res Hepatol Gastroenterol; 2012 Aug; 36(4):357-64. PubMed ID: 22326248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.
    Prajapati HJ; Dhanasekaran R; El-Rayes BF; Kauh JS; Maithel SK; Chen Z; Kim HS
    J Vasc Interv Radiol; 2013 Mar; 24(3):307-15. PubMed ID: 23375519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of 10 prognostic staging systems in patients with advanced hepatocellular carcinoma.
    Wang L; Xian Y; Yang Z
    J BUON; 2019; 24(1):150-157. PubMed ID: 30941964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour staging, morphology and p53 overexpression concur in predicting survival in hepatocellular carcinoma.
    Gianni S; Cecchetto A; Altavilla G; Ragazzi R; Bertazzo M; De Giorgio M; Baldan A; Fagiuoli S; Farinati F
    J Intern Med; 2005 Apr; 257(4):367-73. PubMed ID: 15788007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.